Metastatic Urothelial Cancer

DrugDrug NameDrug Description
DB11945AvelumabAn anti-PD-L1 monoclonal antibody used to treat metastatic merkel cell carcinoma, metastatic urothelial carcinoma, or renal cell carcinoma.
DB00997DoxorubicinA medication used to treat various cancers, including AIDS-associated Kaposi's Sarcoma and metastatic cancers.
DB13007Enfortumab vedotinAn antibody-drug conjugate comprised of a fully human monoclonal antibody and microtubule-disrupting chemotherapeutic agent used in the treatment of advanced or metastatic urothelial cancer.
DrugDrug NameTargetType
DB11945AvelumabProgrammed cell death 1 ligand 1target
DB00997DoxorubicinDNA topoisomerase 2-alphatarget
DB00997DoxorubicinDNAtarget
DB00997DoxorubicinCytochrome P450 3A4enzyme
DB00997DoxorubicinCytochrome P450 2D6enzyme
DB00997DoxorubicinCytochrome P450 2B6enzyme
DB00997DoxorubicinP-glycoprotein 1transporter
DB00997DoxorubicinCanalicular multispecific organic anion transporter 2transporter
DB00997DoxorubicinMultidrug resistance-associated protein 6transporter
DB00997DoxorubicinMultidrug resistance-associated protein 1transporter
DB00997DoxorubicinMultidrug resistance-associated protein 7transporter
DB00997DoxorubicinATP-binding cassette sub-family G member 2transporter
DB00997DoxorubicinBile salt export pumptransporter
DB00997DoxorubicinSolute carrier family 22 member 16transporter
DB00997DoxorubicinATP-binding cassette sub-family B member 8, mitochondrialtransporter
DB00997DoxorubicinCytochrome P450 1B1enzyme
DB00997DoxorubicinCarbonyl reductase [NADPH] 1enzyme
DB00997DoxorubicinCarbonyl reductase [NADPH] 3enzyme
DB00997DoxorubicinAlcohol dehydrogenase [NADP(+)]enzyme
DB00997DoxorubicinAldo-keto reductase family 1 member C3enzyme
DB00997DoxorubicinNAD(P)H dehydrogenase [quinone] 1enzyme
DB00997DoxorubicinXanthine dehydrogenase/oxidaseenzyme
DB00997DoxorubicinNitric oxide synthase, endothelialenzyme
DB00997DoxorubicinNitric oxide synthase, inducibleenzyme
DB00997DoxorubicinNitric oxide synthase, brainenzyme
DB00997DoxorubicinNADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrialenzyme
DB00997DoxorubicinNADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrialenzyme
DB00997DoxorubicinNADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrialenzyme
DB00997DoxorubicinNADPH--cytochrome P450 reductaseenzyme
DB00997DoxorubicinRalA-binding protein 1transporter
DB00997DoxorubicinCanalicular multispecific organic anion transporter 1transporter
DB00997DoxorubicinSerum albumincarrier
DB00997DoxorubicinNucleolar and coiled-body phosphoprotein 1target
DB00997DoxorubicinDNA topoisomerase 1target
DB00997DoxorubicinDNA topoisomerase 2-betatarget
DB00997DoxorubicinAldose reductaseenzyme
DB00997DoxorubicinAldo-keto reductase family 1 member B10enzyme
DB00997DoxorubicinAldo-keto reductase family 1 member C4enzyme
DB13007Enfortumab vedotinCytochrome P450 3A4enzyme
DB13007Enfortumab vedotinNectin-4target
DB13007Enfortumab vedotinP-glycoprotein 1transporter
DrugDrug NamePhaseStatusCount
DB13007Enfortumab vedotin1Completed1
DB09037Pembrolizumab1Completed1
DB12893Sacituzumab govitecan1 / 2Recruiting1
DB11945Avelumab2Completed1
DB11945Avelumab2Recruiting1
DB00958Carboplatin2Completed2
DB00958Carboplatin2Recruiting1
DB00515Cisplatin2Recruiting1
DB13007Enfortumab vedotin2Active Not Recruiting1
DB00441Gemcitabine2Completed2
DB00441Gemcitabine2Recruiting1
DB09035Nivolumab2Completed1
DB09074Olaparib2Completed1
DB00526Oxaliplatin2Completed1
DB01229Paclitaxel2Unknown Status1
DB09037Pembrolizumab2Recruiting1
DB15766Retifanlimab2Completed1
DB12893Sacituzumab govitecan2Recruiting1
DB11836Sapanisertib2Unknown Status1
DB17505Zimberelimab2Recruiting1
DB11945Avelumab2 / 3Recruiting1
DB00958Carboplatin2 / 3Completed1
DB00958Carboplatin2 / 3Recruiting1
DB00515Cisplatin2 / 3Completed1
DB00515Cisplatin2 / 3Recruiting1
DB00441Gemcitabine2 / 3Completed1
DB00441Gemcitabine2 / 3Recruiting1
DB09037Pembrolizumab2 / 3Recruiting1
DB00958Carboplatin3Active Not Recruiting1
DB00515Cisplatin3Active Not Recruiting1
DB11714Durvalumab3Active Not Recruiting1
DB00441Gemcitabine3Active Not Recruiting1
DB11771Tremelimumab3Active Not Recruiting1